Printer Friendly
The Free Library
6,672,335 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Duska Therapeutics, Inc. Announces Listing in Standard & Poor's Corporation Records.


BALA CYNWYD, Pa. -- Duska Therapeutics, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:DSKT) announced today that information describing the company would be made available via Standard & Poor's Corporation Records Listing Program. As part of the program, a full description of Duska Therapeutics will be published in the Daily News Section of Standard Corporation Records, a recognized securities manual for secondary trading in approximately 37 states under the Blue Sky Laws blue sky laws n. laws intended to protect the public from purchasing stock in fraudulent companies that lack substance, such as those selling swamp land, non-existent gold strikes and dry oil wells, or who have no assets besides a post office box. .

Standard Corporation Records is available in print, CD-ROM CD-ROM: see compact disc.
CD-ROM
 in full compact disc read-only memory

Type of computer storage medium that is read optically (e.g., by a laser).
, and via the Web at www.netadvantage.com, as well as through numerous electronic vendors. Duska Therapeutics' listing in Standard Corporation Records may assist the investment community in making a market in Duska Therapeutics' common stock. However, it is recommended that brokers check with the "Blue Sky" laws in their given state.

About Duska Therapeutics, Inc.

Duska Therapeutics, Inc., based in Bala Cynwyd, Pennsylvania is an emerging biopharmaceutical company that is focusing on the development of diagnostic and therapeutic products related to adenosine 5'-triphosphate, or ATP, and ATP related P2 receptors. Duska currently carries out all of its business operations through its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 Duska Scientific Co. Duska owns or has exclusive license rights to four proprietary diagnostic and therapeutic applications that are in various stages of development in the fields of syncope (fainting), male infertility, chronic obstructive pulmonary disease chronic obstructive pulmonary disease
n. Abbr. COPD
A chronic lung disease, such as asthma or emphysema, in which breathing becomes slowed or forced.
 (COPD COPD chronic obstructive pulmonary disease.

COPD
abbr.
chronic obstructive pulmonary disease


Chronic obstructive pulmonary disease (COPD) 
) and asthma.

Company information distributed through the Corporation Records Program is based upon information that Standard & Poor's considers reliable, but neither Standard & Poor's nor its affiliates warrant its completeness or accuracy, and it should not be relied upon as such. This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 7, 2005
Words:277
Previous Article:Marathon PGM Corporation Announces 1.50g/t PGM Intercept Over 26 Metres And Appointment Of A New VP Finance.
Next Article:Verispan Audit Ranks Top 10 Pharma Companies in Long-Term Care; Johnson & Johnson No. 1.



Related Articles
Mailing lists.
Market diary.(Investments & Finance)
Shiprock, Inc. Completes Acquisition of Duska Scientific Co.; Shiprock, Inc. Changes Its Name to Duska Therapeutics, Inc.
Crowding lets criminal get out of jail free.(Crime)(The county releases an inmate it ordinarily wouldn't have thanks to having only 340 beds...
Duska Therapeutics, Inc. Reports on Vagonixen Pre-Clinical Development Work.
No-show adds year to sentence.(Crime)(A burglar who had been offered a 34-month deal gets time tacked on for failing to appear at his sentencing...
Duska Therapeutics Hires Investor Relations International for Strategic IR Effort.
Duska Therapeutics Announces Board Change.
Duska Therapeutics, Inc., Announces Board Changes; Jane Kinsel Rejoins Firm, Replacing Sanford Hillsberg; Donald McAfee Named New Director, Marie...
Duska Therapeutics Announces Escrow Funding of $2 Million Private Placement.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles